Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for AS Latvijas Juras medicinas centrs's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
ORSE:LJM1R'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -66.67 Med: 1.93 Max: 12.5
Current: 2.24
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of AS Latvijas Juras medicinas centrs was 12.50%. The lowest was -66.67%. And the median was 1.93%.
ORSE:LJM1R's Earnings Yield (Joel Greenblatt) % is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 3.88
vs ORSE:LJM1R: 2.24
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. AS Latvijas Juras medicinas centrs's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2025 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AS Latvijas Juras medicinas centrs Earnings Yield (Joel Greenblatt) % Chart
For the Medical Care Facilities subindustry, AS Latvijas Juras medicinas centrs's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AS Latvijas Juras medicinas centrs Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AS Latvijas Juras medicinas centrs's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where AS Latvijas Juras medicinas centrs's Earnings Yield (Joel Greenblatt) % falls into.
AS Latvijas Juras medicinas centrs Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
AS Latvijas Juras medicinas centrs's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.11 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 1.89% mean?
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) has a Earnings Yield (Joel Greenblatt) % of 1.89% as of Dec. 2025. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on AS Latvijas Juras medicinas centrs and its competitors. This is near median its historical median of 1.93.
Is AS Latvijas Juras medicinas centrs' Earnings Yield (Joel Greenblatt) % too high?
AS Latvijas Juras medicinas centrs' current Earnings Yield (Joel Greenblatt) % of 1.89% is near median its 10-year median of 1.93. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.88. AS Latvijas Juras medicinas centrs' value of 1.89% is 51.3% below this industry median. Overall, AS Latvijas Juras medicinas centrs has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does AS Latvijas Juras medicinas centrs' Earnings Yield (Joel Greenblatt) % compare to HCA and THC?
AS Latvijas Juras medicinas centrs' Earnings Yield (Joel Greenblatt) % of 1.89% can be compared against companies in the Healthcare Providers & Services industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.88. AS Latvijas Juras medicinas centrs' value of 1.89% is 51.3% below this benchmark. While the company's 10-year median is 1.93 vs. the industry median of 3.88, AS Latvijas Juras medicinas centrs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.88, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AS Latvijas Juras medicinas centrs's current Earnings Yield (Joel Greenblatt) % of 1.89% is 51.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on AS Latvijas Juras medicinas centrs and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AS Latvijas Juras medicinas centrs's current Earnings Yield (Joel Greenblatt) % is 1.89%, which is near median its own 10-year median of 1.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AS Latvijas Juras medicinas centrs stock overvalued right now?
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) has a current Earnings Yield (Joel Greenblatt) % of 1.89%. The stock's GF Value™ is €7.78, compared to a current price of €7.80 — trading 0.3% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 1.89%, which is near median its 10-year median of 1.93 and 51.3% below the Healthcare Providers & Services industry median of 3.88. AS Latvijas Juras medicinas centrs' overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For AS Latvijas Juras medicinas centrs (ORSE:LJM1R), the current Earnings Yield (Joel Greenblatt) % is 1.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Overvalued in 2026?
Based on GuruFocus' analysis, AS Latvijas Juras medicinas centrs stock appears to be overvalued.
The current stock price of €7.80 is trading 0.3% above its estimated GF Value™ of €7.78.
Key valuation signals for ORSE:LJM1R:
Earnings Yield (Joel Greenblatt) %: 1.89% (near median its 10-year median of 1.93)
GF Value™: €7.78 vs. price of €7.80 (0.3% above fair value)
Industry Position: 51.3% below the Healthcare Providers & Services median
No single metric tells the full story. See the ORSE:LJM1R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AS Latvijas Juras medicinas centrs is a private certified medical institution in Latvia providing outpatient and inpatient healthcare services through qualified staff and modern equipment. Its core activities include hospital services, orthopaedic retail, medical and dental practice, human health and residential care, social work activities, and physical well-being services. It operates the Women's Health Clinic, offering gynecological consultations, pregnancy care, diagnostics, postpartum services, gynecological care for girls, and surgery. The centre also provides vaccination, rehabilitation, a Multiple Sclerosis Center, medical commission, home visits, laboratory services, physical medicine and massage, therapeutic procedures, medical treatment, and anesthesia and intensive care.
59GF Score
Get the complete analysis for ORSE:LJM1R
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORSE:LJM1R has been successfully added to your 
